Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Trichuris trichiura Egg Inoculum

Phase 1Biologic

GGeorge Washington University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2028

Phase 1Recruiting

Infection

NCT05706116

Clinical

Trials by Indication[1]

Infection1 trial

Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults

Recruiting·GGeorge Washington University·Phase 1·NCT05706116·18 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Trichuris trichiura Egg Inoculum. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Trichuris trichiura Egg Inoculum compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Trichuris trichiura Egg Inoculum. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — George Washington University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 1[1]
Company: GGeorge Washington University

Related News